<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>StroomaLab — UB</title>
  <link rel="stylesheet" href="css/main.css" />
</head>
<body>
  <a class="skip-link" href="#main">Skip to content</a>

  <header class="topbar">
    <div class="container nav-wrap">
      <a class="brand" href="index.html" aria-label="StroomaLab Home">
        <span class="brand-badge" aria-hidden="true"></span>
        <div>StroomaLab <span class="dot">•</span> UB</div>
      </a>

      <nav class="navlinks" aria-label="Primary">
        <a href="index.html" aria-current="page">Home</a>
        <a href="research.html">Research</a>
        <a href="people.html">People</a>
        <a href="publications.html">Publications</a>
        <a href="resources.html">Resources</a>
        <a href="contact.html">Contact</a>
      </nav>
    </div>
  </header>

  <main id="main" class="container">
    <section class="hero">
      <h1>Translational Microenvironment Research in Lung Cancer and Lung Fibrosis</h1>
    
      <div class="hero-intro">
        <p class="lead">
          We study the stromal microenvironment and its mechanobiology in lung cancer and pulmonary fibrosis, combining
          patient-derived models, molecular/cell biology, bioengineering, and digital pathology to enable translational insights.
        </p>
      </div>
      <div class="pills" aria-label="Keywords">
        <div class="pill">Lung cancer</div>
        <div class="pill">Pulmonary fibrosis</div>
        <div class="pill">ECM & mechanobiology</div>
        <div class="pill">AFM</div> 
        <div class="pill">Microfluidics </div>  
        <div class="pill"> Digital pathology</div>
      </div>
    </section>

    <section class="grid">
      <article class="card">
        <h2 class="section-title"><span>Research</span> interests overview</h2>

        <p>
          The stroma is the connective tissue rich in fibroblasts and a collagenous extracellular matrix (ECM) that
          surrounds epithelial cells and provides key biomechanical and biochemical cues to guide normal development,
          repair and tissue-specific functions. Conversely, stromal composition and associated signaling becomes chronically
          awry in prevalent and fatal diseases like cancer and organ fibrosis. In the context of the lung, a hallmark of
          both lung cancer and pulmonary fibrosis is a persistent desmoplastic stroma rich in activated fibroblasts/myofibroblasts
          in the background of an excessive deposition of fibrillar collagens, which has been implicated in virtually all steps
          of disease progression and resistance to therapies.
          
        </p>
        
        <p>
          Our lab aims to understand the origins of the pathologic fibrotic
          stroma both in the context of the primary tumor and brain metastasis, how it contributes to disease progression,
          how can it be targeted therapeutically, and how can it be used to identify clinically-relevant biomarkers. For this purpose,
          we combine <b>cutting-edge preclinical models</b> (in culture, in vivo and ex-vivo) based on patient-derived samples
          (including primary fibroblasts and tissue samples from patients with lung cancer or idiopathic pulmonary fibrosis),
          <b>state-of-the-art molecular and cell biology techniques</b> (including “omics”), and <b>bioengineering approaches</b>
          (mainly atomic force microscopy, microfluidics and digital pathology). We then apply these tools to study quantitatively
          the aberrant interactions between fibroblasts and other stromal cells (immune cells, endothelial cells) or epithelial cells
          as well as the aberrant collagenous ECM and associated mechanobiology. 
        
        </p>
        
        <div class="figure">
          <img src="assets/overview.gif" alt="Overview figure of research themes" />
         
        </div>
        <p>

          Our ultimate goal is to be <b>translational</b> and
          bring our knowledge to clinical settings, and to this aim we have ongoing collaborations with clinical groups and collaborate
          with companies to check the suitability of novel drugs against the aberrant stroma as well as novel biomarker for improve
          diagnosis, prognosis and therapeutic guidance.
        </p>

       
      </article>

      <aside class="card">
        <h2 class="section-title"><span>Quick</span> links</h2>
        <ul class="list">
          <li><a href="research.html">Current research projects</a></li>
          <li><a href="people.html">Lab members</a></li>
          <li><a href="publications.html">Publications</a></li>
          <li><a href="resources.html#funding">Funding sources</a></li>
          <li><a href="resources.html#collaborations">Collaborations</a></li>
          <li><a href="resources.html#openings">Open positions</a></li>
          <li><a href="resources.html#support">Support our research</a></li>
        </ul>

        <hr class="hr" />

        <h2 class="section-title"><span>News</span> &amp; highlights</h2>
        <ul class="list">
          <li>
            <a href="https://web.ub.edu/en/web/actualitat/w/researchers-find-recruitment-mechanism-for-cancer-associated-fibroblasts-in-the-most-common-lung-cancer"
              target="_blank" rel="noopener">
              New recruitment mechanisms for cancer-associated fibroblasts in lung adenocarcinoma, 2023
            </a>
          </li>

          <li>
            <a href="https://www.linkedin.com/posts/university-of-barcelona_identificat-un-nou-biomarcador-del-c%C3%A0ncer-activity-7076832047851286528-JpZQ/?utm_source=share&utm_medium=member_desktop"
              target="_blank" rel="noopener">
              Collagen as a novel diagnostic and prognostic biomarker independent of TNM in lung cancer, 2023
            </a>
          </li>

          <li>
            <a href="https://www.elperiodico.com/es/sociedad/20220912/cancer-pulmon-avance-medico-clinic-universitat-barcelona-75326811"
              target="_blank" rel="noopener">
              TIMP-1 as a new therapeutic target in lung adenocarcinoma, 2022
            </a>
          </li>
        </ul>

        <p class="page-nav">
          <a href="resources.html#news">View all news</a>
        </p>
        
      </aside>
    </section>
  </main>

  <footer class="footer footer-pro">
    <div class="container">
      <div class="footer-inner">
  
        <a href="https://www.ub.edu/" target="_blank" rel="noopener" aria-label="University of Barcelona website">
          <img class="footer-logo" src="assets/universitat_icon.png" alt="University of Barcelona logo" loading="lazy">
        </a>
  
        <p class="footer-text">Department of Biomedicine — University of Barcelona</p>
        <p class="footer-copy">© <span id="year"></span> StroomaLab</p>
  
      </div>
    </div>
  </footer>
  
  <script>
    document.getElementById("year").textContent = new Date().getFullYear();
  </script>